Wedge Capital Management L L P Innoviva, Inc. Transaction History

Wedge Capital Management L L P

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 02, 2019	SELL	$13.69 - $20.06 $608,246 - $891,265	-44,430 Closed	0 $0
Q4 2018 Jan 31, 2019	BUY	$13.96 - $18.26 $122,024 - $159,610	8,741 Added 24.49%	44,430 $775,000
Q3 2018 Nov 01, 2018	SELL	$13.63 - $15.7 $395 - $455	-29 Reduced 0.08%	35,689 $544,000
Q2 2018 Jul 31, 2018	SELL	$13.44 - $17.59 $42,524 - $55,654	-3,164 Reduced 8.14%	35,718 $493,000
Q1 2018 May 01, 2018	SELL	$13.8 - $16.99 $70,421 - $86,699	-5,103 Reduced 11.6%	38,882 $648,000
Q4 2017 Jan 31, 2018	BUY	$11.73 - $14.75 $515,944 - $648,778	43,985	43,985 $624,000

225

79.1M

37.6K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.3B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Wedge Capital Management L L P, based on Form 13F filings with the SEC.

Stay updated on Wedge Capital Management L L P with notifications on news.